Loading...
Mach7 Technologies Limited
M7T.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.33
A$-0.01(-1.49%)
Mach7 Technologies Limited (M7T.AX) Financial Performance & Statements
Review Mach7 Technologies Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
43.77%
↑ 43.77%
Operating Income Growth
75.07%
↑ 75.07%
Net Income Growth
-660.45%
↓ 660.45%
Operating Cash Flow Growth
232.09%
↑ 232.09%
Operating Margin
1.40%
↑ 1.40%
Gross Margin
24.67%
↑ 24.67%
Net Profit Margin
-15.52%
↓ 15.52%
ROE
-10.01%
↓ 10.006%
ROIC
0.82%
↑ 0.82%
Mach7 Technologies Limited (M7T.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Mach7 Technologies Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $15.79M | $13.33M | $13.64M | $6.83M |
| Cost of Revenue | $11.94M | $15.91M | $17.03M | $5.88M |
| Gross Profit | $3.85M | -$2.58M | -$3.39M | $945277.00 |
| Gross Profit Ratio | $0.24 | -$0.19 | -$0.25 | $0.14 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.61M | $3.07M | $2.62M | $1.31M |
| Operating Expenses | $3.61M | $3.07M | $2.62M | $3.65M |
| Total Costs & Expenses | $15.55M | $18.99M | $19.64M | $9.53M |
| Interest Income | $0.00 | $0.00 | $25680.00 | $25680.00 |
| Interest Expense | $63760.00 | $29986.00 | $31616.00 | $25680.00 |
| Depreciation & Amortization | $287326.00 | $3.65M | $4.07M | $160170.00 |
| EBITDA | -$4.36M | -$1.85M | -$1.35M | -$2.70M |
| EBITDA Ratio | -$0.28 | -$0.15 | -$0.14 | -$0.40 |
| Operating Income | $242244.00 | -$5.66M | -$6.007M | -$2.86M |
| Operating Income Ratio | $0.02 | -$0.42 | -$0.44 | -$0.42 |
| Other Income/Expenses (Net) | -$8.69M | $124361.00 | $554440.00 | -$2.36M |
| Income Before Tax | -$8.45M | -$5.53M | -$5.45M | -$2.73M |
| Income Before Tax Ratio | -$0.53 | -$0.41 | -$0.40 | -$0.40 |
| Income Tax Expense | -$1.78M | -$896699.00 | -$4.53M | $2.27M |
| Net Income | -$3.34M | -$4.63M | -$917741.00 | -$458870.00 |
| Net Income Ratio | -$0.21 | -$0.35 | -$0.07 | -$0.07 |
| EPS | -$0.01 | -$0.02 | -$0.004 | -$0.002 |
| Diluted EPS | -$0.01 | -$0.02 | -$0.004 | -$0.002 |
| Weighted Avg Shares Outstanding | $241.27M | $240.55M | $240.009M | $239.74M |
| Weighted Avg Shares Outstanding (Diluted) | $241.24M | $240.55M | $240.009M | $239.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan